We present in silico analyses of The Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC) pan-cancer data to highlight the clinical significance and potential downstream targets of NAA10 in human cancers. Here, NAA10 is linked to neoplasm.